Regulation of the growth hormone insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I

被引:30
作者
Wilson, ME [1 ]
机构
[1] Emory Univ, Yerkes Primate Res Ctr, Field Stn, Lawrenceville, GA 30043 USA
关键词
D O I
10.1210/jc.83.6.2018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Developmental changes in the GH-insulin-like growth factor I (IGF-I) axis were evaluated in female rhesus monkeys to test the hypothesis that estradiol differentially regulates IGF-I secretion and molar ratios of IGF-I to IGF-binding protein-3 (IGFBP-3) from adolescence into adulthood and that estradiol can reestablish GH secretion in the face of enhanced IGF-I negative feedback inhibition of GH. Adult ovariectomized females were compared to ovariectomized adolescent females studied hom 18-36 months of age, a period encompassing the juvenile phase through the expected age at first ovulation. A subgroup of adult (n = 5) and adolescent females (n = 5) was treated continuously with human IGF-I (110 mu g/kg.day, sc) throughout the study period and were compared to age-matched, untreated adults (n = 5) and adolescent animals (n = 6). To further understand how IGF-I affects the GH-IGF-I axis, the acute response to IGF-I (100 mu g/kg, sc) was assessed in adults and at two ages in developing females. Furthermore, all females were treated periodically with estradiol (4 mu g/kg.day) to assess the effects on the parameters of the GH-IGF-I axis hom adolescence into adulthood. Finally, the response to GHRH (1.0 mu g/kg, iv) was assessed in adult females and in adolescent females at 18 and 24 months during no estradiol and estradiol replacement. Serum IGF-I and IGFBP-3, in the absence of estradiol replacement, increased significantly throughout puberty before declining from late adolescence into adulthood. Supplementation with IGF-I resulted in a significant increase in both serum IGF-I and IGFBP-3 concentrations at all ages, although the effect was less in juvenile females. Nevertheless, the age-dependent increase and decline in IGF-I and IGFBP-3 were maintained in these supplemented animals. Estradiol replacement significantly increased both serum IGF-I and IGFBP-3 through adolescence, even in IGF-I-supplemented animals. However, with the transition from adolescence, estradiol suppressed serum IGF-I secretion, yet continued to increase IGFBP-3 in young adult and fully adult females. This change in proportionately less IGF-I compared with IGFBP-3 resulted in a significant age-dependent decrease in the molar ratio of IGF-I to IGFBP-3. Indeed, the molar ratio was highest during midadolescence, when both IGF-I and IGFBP-3 were at their zeniths. Serum IGFBP-1 was significantly higher in adolescent compared with adult females. However, estradiol replacement significantly elevated serum IGFBP-1 in adult, but not adolescent, females, abolishing the age differences observed under no estradiol conditions. Serum GH was significantly higher in adolescent compared with adult females; levels in juvenile animals were intermediate. Replacement with estradiol significantly elevated serum GH in adolescent and adult females, particularly in females supplemented with IGF-I. In contrast, estradiol had no effect on serum GH during the juvenile phase. Supplementation with IGF-I significantly dampened the response to GHRH in young and fully adult females, but not in juvenile animals. However, estradiol replacement restored the response to GHRH in these adult, IGF-I-supplemented females. These data indicate that in the absence of any ovarian influence, the decline in serum IGF-I and IGFBP-3 begins in postpubertal, young adult females and is not necessarily a consequence of old age. Furthermore, there is an age-dependent uncoupling of estradiol regulation of the GH-IGF-I suds, as estradiol stimulates GH and IGFBP-3 at all ages but increases serum IGF-I only during adolescent and decreases IGF-I in postpubertal, young adult females. Furthermore, IGF-I has a greater suppressive effect on GH secretion with advancing age, an effect reversed by estradiol replacement. These data suggest that the deficits in the GH-IGF-I axis observed in aged individuals may reflect a continuation of the regulatory changes that begin in young adult females.
引用
收藏
页码:2018 / 2028
页数:11
相关论文
共 76 条
[21]   PULSATILE GROWTH-HORMONE RELEASE IN NORMAL WOMEN DURING THE MENSTRUAL-CYCLE [J].
FARIA, ACS ;
BEKENSTEIN, LW ;
BOOTH, RA ;
VACCARO, VA ;
ASPLIN, CM ;
VELDHUIS, JD ;
THORNER, MO ;
EVANS, WS .
CLINICAL ENDOCRINOLOGY, 1992, 36 (06) :591-596
[22]   Both oral and transdermal estrogen increase growth hormone release in postmenopausal women - A clinical research center study [J].
Friend, KE ;
Hartman, ML ;
Pezzoli, SS ;
Clasey, JL ;
Thorner, MO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06) :2250-2256
[23]   STEROID REGULATION OF GROWTH-HORMONE (GH) RECEPTOR AND GH-BINDING PROTEIN MESSENGER RIBONUCLEIC-ACIDS IN THE RAT [J].
GABRIELSSON, BG ;
CARMIGNAC, DF ;
FLAVELL, DM ;
ROBINSON, ICAF .
ENDOCRINOLOGY, 1995, 136 (01) :209-217
[24]   ADMINISTRATION OF GROWTH-HORMONE (GH), BUT NOT INSULIN-LIKE GROWTH-FACTOR-I (IGF-I), BY CONTINUOUS-INFUSION CAN INDUCE THE FORMATION OF THE 150-KILODALTON IGF-BINDING PROTEIN-3 COMPLEX IN GH-DEFICIENT RATS [J].
GARGOSKY, SE ;
TAPANAINEN, P ;
ROSENFELD, RG .
ENDOCRINOLOGY, 1994, 134 (05) :2267-2276
[25]   THE COMPOSITION AND DISTRIBUTION OF INSULIN-LIKE GROWTH-FACTORS (IGFS) AND IGF-BINDING PROTEINS (IGFBPS) IN THE SERUM OF GROWTH-HORMONE RECEPTOR-DEFICIENT PATIENTS - EFFECTS OF IGF-I THERAPY ON IGFBP-3 [J].
GARGOSKY, SE ;
WILSON, KF ;
FIELDER, PJ ;
VACCARELLO, MA ;
GUEVARAAGUIRRE, J ;
DIAMOND, FB ;
BAXTER, RC ;
ROSENBLOOM, AL ;
ROSENFELD, RG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (06) :1683-1689
[26]   RELATIONSHIP BETWEEN GROWTH HORMONE-RELEASING HORMONE AND SOMATOSTATIN IN THE RAT - EFFECTS OF AGE AND SEX ON CONTENT AND INVITRO RELEASE FROM HYPOTHALAMIC EXPLANTS [J].
GE, F ;
TSAGARAKIS, S ;
REES, LH ;
BESSER, GM ;
GROSSMAN, A .
JOURNAL OF ENDOCRINOLOGY, 1989, 123 (01) :53-58
[27]   Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels .1. A study on ad libitum fed and starved adult male rats [J].
Ghigo, MC ;
Torsello, A ;
Grilli, R ;
Luoni, M ;
Guidi, M ;
Cella, SG ;
Locatelli, V ;
Muller, EE .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1997, 20 (03) :144-150
[28]  
Gil Ad I, 1996, J Endocrinol Invest, V19, P542
[29]  
GOSTELIPETER M, 1994, ENDOCRINOLOGY, V134, P1329
[30]   Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol [J].
Gravholt, CH ;
Naeraa, RW ;
Fisker, S ;
Christiansen, JS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (08) :2570-2577